Investigation of the Validity and Reliability of the The Sustained Auditory Attention Capacity Test in Children with Hearing Loss and Normal Hearing

Project no. 32005 · Status: Kapanmış (Yayın bekleniyor) · 2024

Summary

<p>The&nbsp;aim&nbsp;of&nbsp;the&nbsp;study&nbsp;is&nbsp;to&nbsp;develop&nbsp;the&nbsp;Sustained&nbsp;Auditory&nbsp;Attention&nbsp;Capacity&nbsp;Test&nbsp;(SAACT),&nbsp;evaluate&nbsp;its&nbsp;criterion&nbsp;validity&nbsp;and&nbsp;reliability,&nbsp;and&nbsp;compare&nbsp;the&nbsp;performance&nbsp;of&nbsp;individuals&nbsp;with&nbsp;hearing&nbsp;loss&nbsp;and&nbsp;individuals&nbsp;with&nbsp;normal&nbsp;hearing&nbsp;on&nbsp;the&nbsp;SAACT&nbsp;and&nbsp;Continuous&nbsp;Performance&nbsp;Test&nbsp;(MOXO&nbsp;d-CPT).&nbsp;The&nbsp;study&nbsp;will&nbsp;be&nbsp;conducted&nbsp;in&nbsp;two&nbsp;phases.&nbsp;In&nbsp;the&nbsp;first&nbsp;stage,&nbsp;the&nbsp;words&nbsp;to&nbsp;be&nbsp;used&nbsp;will&nbsp;be&nbsp;determined,&nbsp;audio&nbsp;recordings&nbsp;will&nbsp;be&nbsp;made,&nbsp;and&nbsp;a&nbsp;computer-based&nbsp;test&nbsp;will&nbsp;be&nbsp;developed&nbsp;with&nbsp;the&nbsp;assistance&nbsp;of&nbsp;a&nbsp;computer&nbsp;engineer.&nbsp;In&nbsp;the&nbsp;second&nbsp;stage,&nbsp;the&nbsp;criterion&nbsp;validity&nbsp;and&nbsp;reliability&nbsp;of&nbsp;the&nbsp;test&nbsp;will&nbsp;be&nbsp;evaluated.&nbsp;In&nbsp;this&nbsp;stage,&nbsp;the&nbsp;SAACT&nbsp;will&nbsp;first&nbsp;be&nbsp;administered&nbsp;to&nbsp;all&nbsp;individuals,&nbsp;and&nbsp;the&nbsp;results&nbsp;of&nbsp;the&nbsp;developed&nbsp;test&nbsp;will&nbsp;be&nbsp;compared&nbsp;to&nbsp;examine&nbsp;known&nbsp;group&nbsp;validity.&nbsp;The&nbsp;criterion&nbsp;validity&nbsp;of&nbsp;the&nbsp;SAACT&nbsp;will&nbsp;be&nbsp;assessed&nbsp;using&nbsp;the&nbsp;MOXO&nbsp;d-CPT&nbsp;and&nbsp;the&nbsp;auditory&nbsp;attention&nbsp;subscale&nbsp;of&nbsp;the&nbsp;Children's&nbsp;Auditory&nbsp;Performance&nbsp;Scale&nbsp;(CHAPS).&nbsp;Subsequently,&nbsp;the&nbsp;SAACT&nbsp;will&nbsp;be&nbsp;re-administered&nbsp;to&nbsp;all&nbsp;individuals&nbsp;to&nbsp;assess&nbsp;its&nbsp;test-retest&nbsp;reliability.&nbsp;The&nbsp;test&nbsp;and&nbsp;retest&nbsp;results&nbsp;will&nbsp;be&nbsp;evaluated&nbsp;by&nbsp;determining&nbsp;the&nbsp;intraclass&nbsp;correlation&nbsp;coefficient.&nbsp;The&nbsp;study&nbsp;expects&nbsp;the&nbsp;intraclass&nbsp;correlation&nbsp;coefficient&nbsp;of&nbsp;the&nbsp;test&nbsp;and&nbsp;retest&nbsp;measurements&nbsp;to&nbsp;be&nbsp;at&nbsp;least&nbsp;r=0.6&nbsp;at&nbsp;95%&nbsp;confidence&nbsp;(1-α)&nbsp;and&nbsp;95%&nbsp;test&nbsp;power&nbsp;(1-β).&nbsp;For&nbsp;criterion&nbsp;validity,&nbsp;a&nbsp;meaningful&nbsp;relationship&nbsp;is&nbsp;expected&nbsp;between&nbsp;the&nbsp;SAACT&nbsp;and&nbsp;MOXO&nbsp;d-CPT&nbsp;at&nbsp;95%&nbsp;confidence&nbsp;(1-α),&nbsp;95%&nbsp;test&nbsp;power&nbsp;(1-β),&nbsp;and&nbsp;an&nbsp;effect&nbsp;size&nbsp;of&nbsp;at&nbsp;least&nbsp;r=0.6.&nbsp;Following&nbsp;these&nbsp;stages,&nbsp;the&nbsp;final&nbsp;version&nbsp;of&nbsp;the&nbsp;software&nbsp;will&nbsp;be&nbsp;provided,&nbsp;with&nbsp;corrections&nbsp;made&nbsp;to&nbsp;the&nbsp;software&nbsp;if&nbsp;necessary.&nbsp;The&nbsp;study&nbsp;will&nbsp;include&nbsp;30&nbsp;children&nbsp;aged&nbsp;8-16&nbsp;with&nbsp;hearing&nbsp;loss&nbsp;(using&nbsp;hearing&nbsp;aids&nbsp;and&nbsp;cochlear&nbsp;implants)&nbsp;and&nbsp;30&nbsp;age-&nbsp;and&nbsp;gender-matched&nbsp;children&nbsp;with&nbsp;normal&nbsp;hearing.&nbsp;The&nbsp;study&nbsp;is&nbsp;expected&nbsp;to&nbsp;reveal&nbsp;a&nbsp;statistically&nbsp;significant&nbsp;difference&nbsp;between&nbsp;the&nbsp;MOXO&nbsp;d-CPT&nbsp;and&nbsp;the&nbsp;SAACT.&nbsp;No&nbsp;Turkish&nbsp;auditory&nbsp;attention&nbsp;test&nbsp;has&nbsp;yet&nbsp;been&nbsp;developed&nbsp;for&nbsp;children&nbsp;with&nbsp;hearing&nbsp;loss&nbsp;in&nbsp;the&nbsp;literature.&nbsp;The&nbsp;validity&nbsp;and&nbsp;reliability&nbsp;study&nbsp;of&nbsp;the&nbsp;SİDKT&nbsp;to&nbsp;be&nbsp;conducted&nbsp;in&nbsp;this&nbsp;study&nbsp;on&nbsp;hearing-impaired&nbsp;and&nbsp;normal-hearing&nbsp;individuals&nbsp;aged&nbsp;8-16&nbsp;will&nbsp;contribute&nbsp;to&nbsp;the&nbsp;literature&nbsp;as&nbsp;the&nbsp;first&nbsp;of&nbsp;its&nbsp;kind&nbsp;in&nbsp;this&nbsp;field.</p>

View details